MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,900,939 | -35.3% | 19,864 | +2.3% | 0.02% | -26.1% |
| Q2 2023 | $4,483,248 | -11.3% | 19,408 | -7.0% | 0.02% | -14.8% |
| Q1 2023 | $5,054,997 | +8.0% | 20,866 | +29.4% | 0.03% | +8.0% |
| Q4 2022 | $4,678,830 | +305.8% | 16,120 | +46.5% | 0.02% | +525.0% |
| Q2 2019 | $1,153,000 | -49.8% | 11,000 | -40.0% | 0.00% | -55.6% |
| Q1 2019 | $2,296,000 | +10.0% | 18,333 | -1.1% | 0.01% | -10.0% |
| Q4 2018 | $2,088,000 | -23.5% | 18,528 | +45.4% | 0.01% | 0.0% |
| Q3 2018 | $2,729,000 | -35.1% | 12,746 | -15.2% | 0.01% | -44.4% |
| Q2 2018 | $4,203,000 | +299.9% | 15,028 | +67.0% | 0.02% | +260.0% |
| Q1 2018 | $1,051,000 | +90.7% | 9,000 | +50.0% | 0.01% | +150.0% |
| Q4 2017 | $551,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |